Ensemble modeling of hepatic fatty acid metabolism with a synthetic glyoxylate shunt.
The liver plays a central role in maintaining whole body metabolic and energy homeostasis by consuming and producing glucose and fatty acids. Glucose and fatty acids compete for hepatic substrate oxidation with regulation ensuring glucose is oxidized preferentially. Increasing fatty acid oxidation is expected to decrease lipid storage in the liver and avoid lipid-induced insulin-resistance. To increase hepatic lipid oxidation in the presence of glucose, we previously engineered a synthetic glyoxylate shunt into human hepatocyte cultures and a mouse model and showed that this synthetic pathway increases free fatty acid beta-oxidation and confers resistance to diet-induced obesity in the mouse model. Here we used ensemble modeling to decipher the effects of perturbations to the hepatic metabolic network on fatty acid oxidation and glucose uptake. Despite sampling of kinetic parameters using the most fundamental elementary reaction models, the models based on current metabolic regulation did not readily describe the phenotype generated by glyoxylate shunt expression. Although not conclusive, this initial negative result prompted us to probe unknown regulations, and malate was identified as inhibitor of hexokinase 2 expression either through direct or indirect actions. This regulation allows the explanation of observed phenotypes (increased fatty acid degradation and decreased glucose consumption). Moreover, the result is a function of pyruvate-carboxylase, mitochondrial pyruvate transporter, citrate transporter protein, and citrate synthase activities. Some subsets of these flux ratios predict increases in fatty acid and decreases in glucose uptake after glyoxylate expression, whereas others predict no change. Altogether, this work defines the possible biochemical space where the synthetic shunt will produce the desired phenotype and demonstrates the efficacy of ensemble modeling for synthetic pathway design.
Dean
Jason T
JT
Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, California, USA.
Rizk
Matthew L
ML
Tan
Yikun
Y
Dipple
Katrina M
KM
Liao
James C
JC
D000818:Animals; D005227:Fatty Acids / Q000378:metabolism*; D006038:Glyoxylates / Q000378:metabolism*; D056945:Hep G2 Cells; D022781:Hepatocytes / Q000187:drug effects / Q000201:enzymology; D006593:Hexokinase / Q000037:antagonists & inhibitors; D006801:Humans; D007700:Kinetics; D050356:Lipid Metabolism / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008293:Malates / Q000494:pharmacology; D053858:Metabolic Networks and Pathways / Q000187:drug effects; D051379:Mice; D008954:Models, Biological
D005227:Fatty Acids; D006038:Glyoxylates; D008293:Malates; C030298:malic acid; D006593:Hexokinase
Anal Biochem. 1976 May 7;72:248-54
942051
Am J Physiol. 1998 May;274(5):E843-51
9612242
Cell Metab. 2009 Jun;9(6):525-36
19490907
FEBS Lett. 1996 Jul 29;390(3):258-60
8706872
Biophys J. 2005 Mar;88(3):1616-25
15626710
J Biol Chem. 1978 Nov 25;253(22):8291-3
711752
FEBS Lett. 1998 Nov 27;440(1-2):55-8
9862424
Methods. 2001 Dec;25(4):402-8
11846609
J Biol Chem. 2009 Feb 27;284(9):5457-61
18940807
Gastroenterology. 2008 May;134(6):1682-98
18471547
Metab Eng. 2001 Jan;3(1):27-39
11162230
J Bacteriol. 1993 Nov;175(21):6939-44
8226637
Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112
16447287
Eur J Biochem. 1997 Feb 15;244(1):1-14
9063439
Nucleic Acids Res. 2002 Jan 1;30(1):47-9
11752250
Metab Eng. 1999 Jan;1(1):75-87
10935756
J Biol Chem. 2003 Nov 21;278(47):46446-51
12963713
Nature. 2006 Dec 14;444(7121):875-80
17167476
PLoS One. 2009 Sep 04;4(9):e6903
19730732
Eur J Biochem. 1991 Jan 1;195(1):121-9
1899378
J Theor Biol. 2000 Apr 7;203(3):229-48
10716907
Annu Rev Physiol. 1999;61:663-82
10099705
Am J Physiol Endocrinol Metab. 2003 May;284(5):E855-62
12676647
J Clin Invest. 2004 Jul;114(2):147-52
15254578
Metab Eng. 2009 Jul-Sep;11(4-5):221-33
19379820
Biotechnol Bioeng. 1996 Oct 5;52(1):129-40
18629859
Best Pract Res Clin Gastroenterol. 2002 Oct;16(5):733-47
12406442
Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1676-86
17911349
Biophys J. 2004 Dec;87(6):3750-63
15465856
Diabetologia. 1995 Oct;38(10):1213-7
8690174
Biochem J. 1977 Jul 15;166(1):123-9
143278
Nature. 2006 Dec 14;444(7121):840-6
17167471
Ann Biomed Eng. 2007 Mar;35(3):474-91
17151925
Biophys J. 2008 Dec 15;95(12):5606-17
18820235
FEBS J. 2005 Dec;272(24):6244-53
16336262
Metab Eng. 2003 Jan;5(1):1-15
12749840
Biochim Biophys Acta. 2007 Jun;1768(6):1378-88
17395152
Biotechnol Bioeng. 2000-2001;71(4):286-306
11291038